PUBLISHER: The Business Research Company | PRODUCT CODE: 1946713
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946713
Pain management devices and therapies are used to control chronic and severe pain in patients suffering from various medical conditions, including cancer and neurological disorders. They are primarily used for procedures such as spinal cord stimulation, sacral nerve stimulation, and deep brain stimulation.
The main categories in the pain management devices and therapies market include electrical stimulators, ablation devices, neurostimulators, and analgesic infusion pumps. Electrical stimulation devices include transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, combination therapy units, electrotherapy devices, and TNS systems, while ablation devices include radiofrequency ablation and cryoablation technologies, and neurostimulation devices include spinal cord stimulation (SCS), deep brain stimulation, vagus nerve stimulation, and sacral nerve stimulation systems. Analgesic infusion pumps include intrathecal and external pumps used for managing neuropathic pain, cancer-related pain, facial and migraine pain, musculoskeletal pain, and trauma-related pain.
Tariffs are impacting the pain management devices market by increasing costs of electronic components, implantable device materials, and precision sensors, particularly affecting neurostimulation and infusion pump segments. North America and Asia-Pacific supply chains are most exposed. Positively, tariffs are encouraging domestic manufacturing and innovation in modular, cost-efficient pain management solutions.
The pain management devices and therapies market research report is one of a series of new reports from The Business Research Company that provides pain management devices and therapies market statistics, including pain management devices and therapies industry global market size, regional shares, competitors with a pain management devices and therapies market share, detailed pain management devices and therapies market segments, market trends and opportunities, and any further data you may need to thrive in the pain management devices and therapies industry. This pain management devices and therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pain management devices and therapies market size has grown strongly in recent years. It will grow from $5.34 billion in 2025 to $5.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rising chronic pain prevalence, increased cancer pain cases, opioid-related risks, growth in neurology treatments, hospital adoption of stimulators.
The pain management devices and therapies market size is expected to see strong growth in the next few years. It will grow to $7.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population growth, technological advances in neurostimulators, demand for long-term pain relief, expansion of outpatient pain clinics, increasing healthcare expenditure. Major trends in the forecast period include growing adoption of neurostimulation therapies, rising use of non-opioid pain management, expansion of implantable pain devices, increasing demand for chronic pain treatments, shift toward minimally invasive pain procedures.
The rising prevalence of chronic pain conditions is increasingly supporting the expansion of the pain management devices and therapies market going forward. Chronic pain conditions involve persistent or recurring pain lasting three months or longer and often interfere with daily activities and overall quality of life. The growing prevalence of chronic pain is closely linked to aging populations, as older adults are more vulnerable to degenerative joint diseases and long-term health conditions that cause continuous discomfort. Pain management devices and therapies provide targeted, non-invasive relief suitable for long-term use, offering consistent and personalized pain control that improves patient comfort and quality of life. For example, in November 2024, according to the National Center for Health Statistics, a US-based federal agency, approximately 24.3% of adults in the United States experienced chronic pain in 2023. As a result, the increasing prevalence of chronic pain conditions is reinforcing growth in the pain management devices and therapies market.
Leading companies operating in the pain management devices and therapies market are developing advanced neuromodulation technologies, such as closed-loop spinal cord stimulation systems, to deliver personalized pain relief and improve therapy effectiveness. Closed-loop spinal cord stimulation systems continuously monitor neural responses and automatically adjust stimulation in real time to maintain consistent pain relief. For example, in April 2024, Medtronic plc received FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator for chronic pain treatment. The fully implantable device uses proprietary sensing technology to capture biological signals and deliver data-driven therapy with automatic real-time adjustment, reducing the need for patient intervention.
In April 2025, Globus Medical Inc., a US-based musculoskeletal technology company, acquired Nevro Corp. for an undisclosed amount. With this acquisition, Globus Medical aims to accelerate market adoption of Nevro's differentiated high-frequency technology and broaden treatment options for patients suffering from chronic pain. Nevro Corp. is a US-based medical device company specializing in high-frequency spinal cord stimulation systems for chronic pain management.
Major companies operating in the pain management devices and therapies market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Baxter International Inc., Johnson & Johnson, Smiths Medical Inc., Becton Dickinson and Company, DJO Global Inc., B Braun Melsungen AG, Neurotech Na, Nevro Corp, NeuroMetrix Inc, Medovex Corporation, Halyard Health Inc, Flowonix Medical Inc, Pain Management Technologies Inc, Avanos Medical Inc, Stimwave Technologies LLC, Omron Healthcare Inc., Stryker Corporation, ICU Medical Inc., Nipro Corporation, Zynex Medical Inc., Saluda Medical Pty Ltd., SPR Therapeutics
North America was the largest region in the pain management devices and therapies market in 2025. Western Europe was the second-largest region in the pain management devices and therapies market report. The regions covered in the pain management devices and therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pain management devices and therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pain management devices and therapies market consist of sales of physical therapy, massage, acupuncture, osteopathic manipulative treatment (OMT) and chiropractic adjustments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pain Management Devices And Therapies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pain management devices and therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pain management devices and therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pain management devices and therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.